Marinus Pharmaceuticals downgraded by RBC Capital Mkts with a new price target

4/15/24 12:58:09 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

RBC Capital Mkts downgraded Marinus Pharmaceuticals from Outperform to Sector Perform and set a new price target of $3.00 from $24.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MRNS

Date	Price Target	Rating	Analyst
9/23/2024	$6.00	Perform → Outperform	Oppenheimer
8/14/2024		Buy → Neutral	Ladenburg Thalmann
4/16/2024	$20.00 → $2.00	Outperform → Neutral	Robert W. Baird
4/15/2024	$24.00 → $3.00	Outperform → Sector Perform	RBC Capital Mkts
8/11/2023	$14.00 → $9.00	Outperform → Perform	Oppenheimer
1/20/2023	$23.00	Outperform	RBC Capital Mkts
12/20/2021	$32.00 → $30.00	Outperform	SVB Leerink